RedHill Biopharma (RDHL) EBT Margin Growth (1y) (2013 - 2023)
RedHill Biopharma (RDHL) EBT Margin Growth (1y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | RedHill Biopharma | 1.99 Bn | 1.99 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 324,467.00 |
| Mar 31, 2023 | -31,718.00 |
| Dec 31, 2022 | 10,107.00 |
| Sep 30, 2022 | -18,446.00 |
| Jun 30, 2022 | -6,003.00 |
| Mar 31, 2022 | 3,182.00 |
| Dec 31, 2021 | -69,338.00 |
| Sep 30, 2021 | 1,296.00 |
| Jun 30, 2021 | 5,320.00 |
| Mar 31, 2021 | -149,215.00 |
| Dec 31, 2020 | -69,537.00 |
| Sep 30, 2020 | -68,038.00 |
| Jun 30, 2020 | -86,087.00 |
| Mar 31, 2020 | 106,491.00 |
| Dec 31, 2019 | -16,812.00 |
| Sep 30, 2019 | 30,387.00 |
| Jun 30, 2019 | 56,346.00 |
| Mar 31, 2019 | 8,133.00 |
| Dec 31, 2018 | -291.00 |
| Sep 30, 2018 | -38,975.00 |